The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
Abstract
The progressive degenerative process associated with sporadic Parkinson's disease (sPD) is characterized by formation of alpha-synuclein-containing inclusion bodies in a few types of projection neurons in both the enteric and central nervous systems (ENS and CNS). In the brain, the process apparently begins in the brainstem (dorsal motor nucleus of the vagal nerve) and advances through susceptible regions of the basal mid-and forebrain until it reaches the cerebral cortex. Anatomically, all of the vulnerable brain regions are closely interconnected. Whether the pathological process begins in the brain or elsewhere in the nervous system, however, is still unknown. We therefore used immunocytochemisty to investigate the gastric myenteric and submucosal plexuses in 150 microm cryosections and 8 microm paraffin sections from five autopsy individuals, whose brains were also staged for Parkinson-associated synucleinopathy. alpha-synuclein immunoreactive inclusions were found in neurons of the submucosal Meissner plexus, whose axons project into the gastric mucosa and terminate in direct proximity to fundic glands. These elements could provide the first link in an uninterrupted series of susceptible neurons that extend from the enteric to the central nervous system. The existence of such an unbroken neuronal chain lends support to the hypothesis that a putative environmental pathogen capable of passing the gastric epithelial lining might induce alpha-synuclein misfolding and aggregation in specific cell types of the submucosal plexus and reach the brain via a consecutive series of projection neurons.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“During the first stages of PD, neurons of the ENS and the olfactory bulbs (OB) were found to contain aggregated and phosphorylated alpha-synuclein (Braak et al., 2006;Shannon et al., 2012b).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Braak et al., 2006
In the citing paper
“Several clinical studies revealed that PD patients expressed alphasynuclein accumulation in the ENS (Braak et al., 2006;Forsyth et al., 2011;Gelpi et al., 2014;Gold et al., 2013;Sánchez-Ferro et al., 2015;Shannon et al., 2012a).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Braak et al., 2006
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citationStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Self-citationSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Self-citationBraak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Self-citationGastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00307-7 · Cited by 933
Where Does Parkinson Disease Pathology Begin in the Brain?
Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773
Self-citationParkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., & Ikuta, F. (1988) · Acta Neuropathologica · doi:10.1007/bf00687767 · Cited by 528
Anatomy and physiology of the enteric nervous system
Costa, M., Brookes, S., & Hennig, G. (2000) · Gut · doi:10.1136/gut.47.suppl_4.iv15 · Cited by 364
Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough
Lang, A. E., & Obeso, J. A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00740-9 · Cited by 348
Wakabayashi, K., Takahashi, H., Ohama, E., & Ikuta, F. (1990) · Acta Neuropathologica · doi:10.1007/bf00294234 · Cited by 324
Esophageal Lewy bodies associated with ganglion cell loss in achalasia
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90079-9 · Cited by 305
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · PubMed · Cited by 295
Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62
Kuusisto, E., Parkkinen, L., & Alafuzoff, I. I. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1241 · Cited by 291
Chapter 15 Chemical coding of enteric neurons
Costa, M., Furness, J. B., & Gibbins, I. L. (1986) · Progress in brain research · doi:10.1016/s0079-6123(08)60241-1 · Cited by 285
Neuropathology of synuclein aggregates
Duda, J. E., Lee, V. M. ‐., & Trojanowski, J. Q. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000715)61:2 · Cited by 263
Fenoglio‐Preiser, C. M., Lantz, P., Listrom, M. B., Davis, M. E. M., & Rilke, F. O. (1991) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199101000-00033 · Cited by 257
Saper, C., Wainer, B. H., & German, D. C. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90063-7 · Cited by 239
Anlauf, M., Schäfer, M. K.-H., Eiden, L. E., & Weihe, E. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10599 · Cited by 213
Lewy bodies in the visceral autonomic nervous system in Parkinson's disease.
Wakabayashi, K., Takahashi, H. E., Ohama, E., Takeda, S., & Ikuta, F. (1993) · PubMed · Cited by 154
Chapter 5 Vagal efferent projections: viscerotopy, neurochemistry and effects of vagotomy
Hopkins, D. A., Bieger, D., de Vente, J., & Steinbusch, H. W. M. (1996) · Progress in brain research · doi:10.1016/s0079-6123(08)61859-2 · Cited by 141
The cellular pathology of Parkinson's disease
Takahashi, H., & Wakabayashi, K. (2001) · Neuropathology · doi:10.1046/j.1440-1789.2001.00403.x · Cited by 109
Walker, L. C., & LeVine, H. (2000) · Molecular Neurobiology · doi:10.1385/mn:21:1-2:083 · Cited by 105
Ahlskog, J. E. (2004) · Movement Disorders · doi:10.1002/mds.20362 · Cited by 83
Gastrointestinal Dysfunction in Parkinson's Disease
Quigley, E. M. M. (1996) · Seminars in Neurology · doi:10.1055/s-2008-1040981 · Cited by 74
Link between Helicobacter pylori infection and idiopathic parkinsonism
Dobbs, S. M., Dobbs, R. J., Weller, C., & Charlett, A. (2000) · Medical Hypotheses · doi:10.1054/mehy.2000.1110 · Cited by 61
Altschuler, E. (1996) · Medical Hypotheses · doi:10.1016/s0306-9877(96)90223-6 · Cited by 57
Neurochemical coding of myenteric neurones in the human gastric fundus
Pimont, S., Varannes, S. B. D., Néel, J., et al. (2003) · Neurogastroenterology & Motility · doi:10.1046/j.1350-1925.2003.00442.x · Cited by 40
Cortical Connections and the Pathology of Alzheimer's Disease
Pearson, R. C. A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0058 · Cited by 40
Molecular Mechanisms of Parkinson's Disease
Rezaee, Z., Marandi, M., Alaei, H., & Esfarjani, F. (2019) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.8.1.120 · Cited by 30
Alpha-synuclein. Axonal transport, ligand interaction and neurodegeneration.
Jensen, P. H., & Gai, W. (2001) · PubMed · Cited by 22
Neuropathology and Genetics of Dementia
Tolnay, M., & Probst, A. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1249-3 · Cited by 15
Neuropathology and Genetics of Dementia
Li, J. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02264-x · Cited by 7
Cited by
Sorted by citations
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
The gut microbiome in neurological disorders
Cryan, J. F., O'Riordan, K. J., Sandhu, K., Peterson, V., & Dinan, T. G. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30356-4 · Cited by 1,336
Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190
Self-citation
Metadata
- Authors
- Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Braak, Heiko
- ORCID
- Braak, Heiko
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 396
- Issue
- 1
- Pages
- 67-72
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2142483035
- Semantic Scholar
- 7f376c4b1f3f257ebbc010f8a10aba2ddeebcdcd
- Cited by
- 1,354
- References
- 33
- Citations by year
- 2026: 61 · 2025: 76 · 2024: 82 · 2023: 83 · 2022: 111 · 2021: 128 · 2020: 92 · 2019: 85 · 2018: 72 · 2017: 81 · 2016: 70 · 2015: 55 · 2014: 59 · 2013: 48 · 2012: 61
- FWCI
- 9.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, alpha-synuclein, synucleinopathies, submucosal plexus, myenteric plexus, submucosal neurons, enteric nervous system, brainstem, neurodegeneration
- MeSH terms
- Aged, Aged, 80 and over, Axonal Transport, Brain, Inclusion Bodies, Female, Gastric Mucosa, Humans, Male, Middle Aged, Models, Neurological, Myenteric Plexus, Nerve Net, Neural Pathways, Neurons, Parkinson Disease, Prions, Submucous Plexus, Vagus Nerve, Protein Folding, Disease Transmission, Infectious, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review